A study led by�NYU Langone Health researchers sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.� ...

A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

There is something special going on inside NYU Langone’s thoracic surgery service line.  Not only does the thoracic surgery team perform more surgeries than the national average, it reports no 30- and ...

Joanne Liu says her alma mater’s health system pulled her talk, which included discussions of funding cuts to humanitarian ...

NYU Langone's Federal Work Study Program offers STEM students hands-on research experience with faculty mentors. Gain skills & boost your science career.

NYU Langone Health tapped Alec Kimmelman to succeed Robert Grossman as its next CEO and dean of the NYU Grossman School of ...

(Gray News) - Death appears to be “reversible” with proper treatment, according to a doctor and professor at New York ...

NYU Langone Health on Monday named Dr. Alec Kimmelman as its next CEO and dean of New York University's Grossman School of Medicine. Kimmelman, who has been leading NYU Langone's Laura and Isaac ...

The appointment comes almost a year after Grossman and Kenneth Langone, chair of NYU’s board of trustees, announced their ...

The announcement by NYU Langone’s Board of Trustees was praised by Kenneth Langone, board chair and co-chair of the search ...

New York City based NYU Langone Health has selected Alec Kimmelman, MD, PhD, as the next CEO and dean of NYU Grossman School of Medicine, effective Sept. 1. Dr. Kimmelman, a researcher and radiation ...